血管改造的调解者被选择用于肺转移的连续步骤
Gaorav P Gupta1, Don X Nguyen, Anne C Chiang
1Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
Nature
|April 13, 2007
概括
这项研究揭示了epiregulin,COX2和矩阵金属蛋白酶如何通过帮助瘤血管形成,细胞释放和肺毛细血管入侵来促进乳腺癌转移. 这些发现为减少肺转移提供了新的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 转移是一种复杂的过程,涉及癌细胞从原发性瘤扩散到遥远的器官.
- 了解推动转移的分子机制对于开发有效的癌症疗法至关重要.
研究的目的:
- 研究epiregulin,循环氧化酶-2 (COX2) 和矩阵金属蛋白酶 (MMPs) 在促进乳腺癌转移中的作用.
- 阐明原发性瘤功能与肺转移潜力之间的机械联系.
主要方法:
- 在人类乳腺癌细胞中利用遗传和药理方法.
- 评估了epiregulin,COX2和MMPs对血管生成,瘤细胞循环和肺毛细血管扩散的影响.
主要成果:
- 乳腺癌细胞中Epiregulin,COX2和MMPs (1和2) 的表达,共同促进新的血管组合 (血管生成).
- 这些因素有助于瘤细胞释放到血液中.
- 它们还使循环中的瘤细胞能够突破肺毛细血管,导致肺转移.
结论:
- 侵袭性原发性瘤功能与增加的肺转移潜力有机结合.
- 向epiregulin,COX2和MMP,可能与药物组合一起,可能提供抑制转移的治疗策略.
相关概念视频
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...


